| Bid Price | High Price | ||
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 26, 2017 | 90.00 | 90.25 | 86.75 | 86.75 | 64,714 |
| Jul 25, 2017 | 90.00 | 90.50 | 87.00 | 90.25 | 29,761 |
| Jul 24, 2017 | 89.00 | 90.00 | 86.00 | 90.00 | 123,263 |
| Jul 21, 2017 | 86.00 | 90.25 | 88.63 | 89.38 | 56,318 |
| Jul 20, 2017 | 90.25 | 90.50 | 88.25 | 89.00 | 36,305 |
| Company Name | Circassia Pharmaceuticals | Epic | CIR |
|---|---|---|---|
| ISIN | GB00BJVD3B28 | Index | n/a |
| EMS | 5,000 | Prev Close | 86.75 |
| Shares in Issue (m) | 332.57 | Market Cap (£m) | 288.50 |
| PE Ratio | -1.81 | Div per Share (p) | 0.00 |
| Div Yield | 0.00 | Div Cover | 0.00 |
| EPS | -48.00 | EPS Growth (%) | -140.00 |
| PEG | 0.01 | DPS Growth (%) | n/a |
| ROCE | -46.35 | Net Gearing | -13.17 |
| Quick Ratio | 6.22 | Current Ratio | 6.44 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 26 May | Numis | Buy | 89.38 | 174.00 | 174.00 | Reiterates |
| 23 May | JP Morgan Cazenove | Neutral | 89.38 | 120.00 | 120.00 | Reiterates |
| 26 Apr | Peel Hunt | Hold | 89.38 | 150.00 | 130.00 | Downgrades |
| 25 Apr | Numis | Buy | 89.38 | 174.00 | 174.00 | Reiterates |
| 25 Apr | Stifel | Buy | 89.38 | 150.00 | 150.00 | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 17 Jul 2017 | Steven Harris | Exercise | 535,375 @ 0.08p | £428.30 |
| 18 Sep 2015 | Charles Swingland | Sell | 1,230,000 @ 318.24p | £3,914,352.00 |
| 18 Sep 2015 | Charles Swingland | Sell | 9,000 @ 318.72p | £28,684.80 |
| 18 Sep 2015 | Charles Swingland | Sell | 754,548 @ 320.24p | £2,416,364.52 |
| 27 Mar 2014 | Dr Rod Hafner | Exercise | 212,375 @ 0.08p | £169.90 |
